Basel Medical (BMGL) Common Equity (2024 - 2025)
Basel Medical's (BMGL) quarterly Common Equity came in at $4.2 million in Q2 2025, down 25.25% year-on-year from $5.6 million in Q2 2024, and down 42.47% quarter-over-quarter from $7.3 million in Q4 2024.
Basel Medical (BMGL) Common Equity (2024 - 2025) Analysis & Trends
Basel Medical has disclosed Common Equity across 2 years of filings, most recently posting $4.2 million for Q2 2025.
- Common Equity for Q2 2025 came in at $4.2 million, down 25.25% year-over-year; the trailing twelve-month figure through Jun 2025 was $4.2 million (down 25.25% YoY), and the FY2025 annual result was $4.3 million, down 23.37% from the prior year.
- Common Equity came in at $4.2 million for Q2 2025 at Basel Medical, down from $7.3 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $7.3 million in Q4 2024 to a low of $4.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -2.98 Bn |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 4.81 Bn |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | -476.34 Mn |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 3.31 Bn |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 2.37 Bn |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 7.46 Bn |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 16.63 Bn |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 847.99 Mn |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 1.04 Bn |
| 10 | Basel Medical | 8.86 Mn | 6.52 Mn | - | 4.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.18 Mn |
| Dec 31, 2024 | 7.26 Mn |
| Jun 30, 2024 | 5.59 Mn |